Indeed, further pathological analyses showed reduction of SETD1B, CD24, N-cadherin and Ki67 following Trip treatment in the tumor xenografts, but reduction of these proteins was no longer seen with SETD1B KD (Figure 8E-G). The gene discussed is CDH2; the disease is neoplasm.